Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 April 2025 | Story Precious Shamase | Photo Kaleidoscope Studios
Sellwane Moloi
Sellwane Jeanette Moloi celebrates graduating with a PhD in plant stress biology, contributing vital research toward global food security through drought-tolerant wheat studies.

Embarking on a PhD is a transformative journey, one filled with intellectual challenges, personal growth, and the potential to contribute meaningfully to one's field. For Sellwane Jeanette Moloi – who has graduated with her PhD on Friday 4 April during the afternoon session – the path was illuminated by a deep fascination with plants and a determination to address the critical issue of global food security.

 

A spark of curiosity

"The initial spark came from a deep curiosity about plants," Moloi shared. "I was intrigued by how plants function and the key mechanisms that help them survive when exposed to various environmental stress factors. Learning different techniques used to study and analyse plant responses to environmental factors made me even more intrigued." This curiosity fuelled a rigorous exploration into plant stress biology, focusing on how wheat thrives under drought conditions.

 

Navigating the challenges

Reflecting on the experience, however, the PhD journey was not without its hurdles. "One of the most challenging aspects was staying motivated and managing pressure," Moloi confessed. "Setbacks and slow progress can also be overwhelming." Overcoming these obstacles required a strategic approach: "I had to break down larger tasks into manageable tasks and also seek support from my supervisors."

Doubts inevitably arose, especially when experiments did not go as planned. "There were moments when I asked myself what I had actually gotten myself into," she admitted. However, the unwavering support of supervisors, colleagues, friends, and family provided the necessary reassurance. "They always assured me things would work out; I needed to hang in there."

 

Key discoveries and achievements

Amid the challenges, significant discoveries were made. Notably, Moloi found that a drought-tolerant wheat variety suppressed photosynthesis as a potential strategy to avert oxidative stress damage, maintaining cell membrane integrity during stressful conditions. This unexpected turn stressed the complexity of plant survival mechanisms.

Moloi’s dedication and hard work culminated in significant achievements, including winning the best PhD poster in plant physiology at the 46th South Africa Association of Botanists Conference in 2020, 3rd Prize at the University of Johannesburg Postgraduate Symposium in 2023 and publishing two research articles in high-impact journals. These accomplishments are a testament to her research prowess and contribution to the field.

 

Developing essential skills

Beyond the research itself, the PhD journey fostered critical skills vital for future success. ‘Critical thinking, logical reasoning, and problem-solving’ were highlighted as key takeaways. "As a PhD student, your mind is constantly engaged in critically analysing results and providing logical reasoning. I believe these skills are valuable in tackling certain situations and providing solutions to problems."

 

Balancing life and research

Balancing research with other aspects of life proved challenging. "That was challenging, but I created a schedule that worked for me," the graduand explained. "This included dedicating certain days (weekends or holidays) or hours to specific tasks, such as lab work or writing. One thing I would advise a PhD student is that they should make time to rest to avoid burnout."


Contribution to food security

Moloi's research holds significant implications for global food security, a pressing issue in the face of climate change and a growing population. "I hope my research will provide insight into how wheat as a cereal crop thrives under drought stress conditions, and the information can be used by plant breeding initiatives in developing more drought-tolerant crops," she stated. "The opportunity to contribute to the field of plant stress biology – my research focuses on understanding plant response mechanisms under drought, and acquiring such information can address issues related to global food security."


Advice for future PhD candidates

For students embarking on their PhD journey, Moloi offered valuable advice: "This degree requires one to be highly motivated and ask for help whenever there are setbacks. There will always be setbacks in research; you need to go back to the drawing board and look for solutions." She also emphasised the importance of seeking support for mental and emotional well-being. "It is okay to feel overwhelmed; the work can be too much at times. Students need to ask for help. We have professionals on campus who can assist with mental or emotional issues."

Furthermore, Moloi shared personal lessons: "Time management and prioritising important tasks. I also learned that it is important to allow yourself to rest. This degree can affect your mental or emotional health." And a candid reflection: "I did not have much of a social life, and I spent most of my time in the lab."

 

Looking ahead

With a PhD in hand, Moloi aspires to become an expert in her field, collaborating with other researchers and mentoring future students. Her journey exemplifies the dedication, resilience, and intellectual curiosity required to excel in academia and contribute to addressing pressing global challenges.

The university provided essential support throughout her studies, ensuring access to facilities even during the COVID-19 pandemic. "I always had access to the facilities on campus to do my research, even during the COVID-19 pandemic."

Celebrating milestones along the way was crucial, with fellow postgraduates sharing in each other's achievements. "My fellow postgraduates and I often went out for lunch to celebrate everyone's achievements." And the support system was extensive: "Everyone – family, supervisors, friends, and colleagues.”

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept